Nonalcoholic Steatohepatitis-Reply
- PMID: 32870294
- DOI: 10.1001/jama.2020.10437
Nonalcoholic Steatohepatitis-Reply
Comment on
-
Nonalcoholic Steatohepatitis.JAMA. 2020 Sep 1;324(9):899. doi: 10.1001/jama.2020.10434. JAMA. 2020. PMID: 32870291 No abstract available.
Similar articles
-
Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.Exp Clin Transplant. 2016 Feb;14(1):79-85. doi: 10.6002/ect.2015.0089. Epub 2015 Nov 17. Exp Clin Transplant. 2016. PMID: 26581602
-
Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis.Gastroenterol Clin North Am. 2020 Mar;49(1):151-164. doi: 10.1016/j.gtc.2019.09.004. Epub 2019 Dec 24. Gastroenterol Clin North Am. 2020. PMID: 32033761 Review.
-
Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.BMC Gastroenterol. 2018 Apr 19;18(1):51. doi: 10.1186/s12876-018-0776-0. BMC Gastroenterol. 2018. PMID: 29673321 Free PMC article. Review.
-
Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.Clin Liver Dis. 2018 Feb;22(1):73-92. doi: 10.1016/j.cld.2017.08.004. Clin Liver Dis. 2018. PMID: 29128062 Review.
-
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Mol Aspects Med. 2017 Aug;56:34-44. doi: 10.1016/j.mam.2017.04.004. Epub 2017 May 5. Mol Aspects Med. 2017. PMID: 28442273 Free PMC article. Review.
Cited by
-
MicroRNAs and Nonalcoholic Steatohepatitis: A Review.Int J Mol Sci. 2023 Sep 23;24(19):14482. doi: 10.3390/ijms241914482. Int J Mol Sci. 2023. PMID: 37833930 Free PMC article. Review.
-
Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.BMJ Open. 2023 Jul 3;13(7):e070431. doi: 10.1136/bmjopen-2022-070431. BMJ Open. 2023. PMID: 37400234 Free PMC article.
-
The effect of liver disease on hepatic microenvironment and implications for immune therapy.Front Pharmacol. 2023 Aug 7;14:1225821. doi: 10.3389/fphar.2023.1225821. eCollection 2023. Front Pharmacol. 2023. PMID: 37608898 Free PMC article. Review.
-
Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis.Exp Mol Med. 2025 Aug 1. doi: 10.1038/s12276-025-01499-w. Online ahead of print. Exp Mol Med. 2025. PMID: 40744994
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical